[go: up one dir, main page]

ATE158172T1 - Pulverförmige pharmazeutische zusammensetzung - Google Patents

Pulverförmige pharmazeutische zusammensetzung

Info

Publication number
ATE158172T1
ATE158172T1 AT92304712T AT92304712T ATE158172T1 AT E158172 T1 ATE158172 T1 AT E158172T1 AT 92304712 T AT92304712 T AT 92304712T AT 92304712 T AT92304712 T AT 92304712T AT E158172 T1 ATE158172 T1 AT E158172T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
powder pharmaceutical
carrier
chitin
pharmaceutically
Prior art date
Application number
AT92304712T
Other languages
English (en)
Inventor
Patricia Elaine Koochaki
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE158172T1 publication Critical patent/ATE158172T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92304712T 1992-05-26 1992-05-26 Pulverförmige pharmazeutische zusammensetzung ATE158172T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92304712A EP0571671B1 (de) 1992-05-26 1992-05-26 Pulverförmige pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE158172T1 true ATE158172T1 (de) 1997-10-15

Family

ID=8211374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92304712T ATE158172T1 (de) 1992-05-26 1992-05-26 Pulverförmige pharmazeutische zusammensetzung

Country Status (7)

Country Link
EP (1) EP0571671B1 (de)
JP (1) JPH07507303A (de)
AT (1) ATE158172T1 (de)
AU (1) AU669902B2 (de)
CA (1) CA2136607C (de)
DE (1) DE69222295T2 (de)
WO (1) WO1993024149A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
DE4404011A1 (de) * 1994-02-09 1995-08-10 Jenapharm Gmbh Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen
DK0943326T4 (da) * 1996-02-27 2007-01-22 Teijin Ltd Pulveragtigt præparat til nasal administration
NZ505919A (en) * 1998-01-30 2002-10-25 Novartis Consumer Health S Nasal solutions
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
JPS62236862A (ja) * 1986-04-09 1987-10-16 Nippon Kayaku Co Ltd 人工粘液
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici

Also Published As

Publication number Publication date
WO1993024149A1 (en) 1993-12-09
CA2136607A1 (en) 1993-12-09
EP0571671A1 (de) 1993-12-01
JPH07507303A (ja) 1995-08-10
DE69222295D1 (de) 1997-10-23
AU669902B2 (en) 1996-06-27
DE69222295T2 (de) 1998-04-09
CA2136607C (en) 2000-04-04
EP0571671B1 (de) 1997-09-17
AU4223493A (en) 1993-12-30

Similar Documents

Publication Publication Date Title
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
DE3688674D1 (de) Hydroxypropylcelluloseether enthaltende mittel mit verzoegerter wirkstoffabgabe.
ATE131039T1 (de) Arzneimittel in gelform in einem spender.
WO1995017156A3 (en) Ethanol substitutes
MY100721A (en) Therapeutic agent.
EP0995434A3 (de) Medizinische Aerosolformulierungen
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69022876D1 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
MY112915A (en) Multiple unit tableted dosage form 1
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
NZ501066A (en) Pharmaceutical formulations containing voriconazole and sulphobutylether beta-cyclodextrin
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
ATE469644T1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
AU4519399A (en) Anti-inflammatory pharmaceutical formulations
ES2109681T3 (es) Composiciones colorantes estables a la luz.
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
YU47573B (sh) Postupak za dobivanje čvrstog farmaceutskog preparata
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee